There is a lower risk of 1-year ventricular arrhythmias or death in women with nonischemic cardiomyopathy and an implantable cardioverter defibrillator (ICD) compared with men.

GLP-1RAs were associated with lower risk for major adverse cardiovascular and cerebrovascular events in MGUS with type 2 diabetes.

A study has found that greater cancer risk is associated with worse cardiovascular health metrics and cardiovascular disease risk scores.

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

Adults with learning disabilities and newly diagnosed type 2 diabetes (T2D) have better short-term glycemic control.

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...

There is no association between atrial fibrillation and increased poststroke dementia risk in patients with first-ever acute ischemic stroke.

Topline data were announced from a trial evaluating vericiguat in patients with stable chronic heart failure and reduced ejection fraction.

Topline results were announced from a phase 3 trial evaluating the safety, tolerability, and immunogenicity of Pfizer-BioNTech’s LP.8.1-adapted COVID-19 vaccine.

An ambient documentation technology (ADT) reduces burnout and improves perceived documentation-related well-being for US clinicians.

For patients with acute myocardial infarction (MI), beta-blockers are not beneficial in those without reduced left ventricular ejection fraction (LVEF).

Semaglutide was associated with a significantly greater reduction in MACE risk vs tirzepatide in patients with overweight/obesity and CVD.